First Manhattan CO Amgen Inc Transaction History

First Manhattan CO

$29.7 Billion
Q2 2024

A detailed history of First Manhattan CO transactions in Amgen Inc stock. As of the latest transaction made, First Manhattan CO holds 113,969 shares of AMGN stock, worth $36 Million. This represents 0.12% of its overall portfolio holdings.

Number of Shares

113,969

Previous 113,969 -0.0%

Holding current value

$36 Million

Previous $35.6 Million -0.0%

% of portfolio

0.12%

Previous 0.12%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$262.75 - $319.31 $1.45 Million - $1.76 Million	-5,513 Reduced 4.61%	113,969 $35.6 Million
Q1 2024 May 15, 2024	SELL	$268.87 - $324.56 $810,105 - $977,899	-3,013 Reduced 2.46%	119,482 $34 Million
Q4 2023 Feb 13, 2024	SELL	$255.7 - $288.46 $1.06 Million - $1.2 Million	-4,144 Reduced 3.27%	122,495 $35.3 Million
Q3 2023 Nov 14, 2023	SELL	$218.65 - $271.46 $727,011 - $902,604	-3,325 Reduced 2.56%	126,639 $34 Million
Q2 2023 Aug 14, 2023	SELL	$214.27 - $253.37 $1.25 Million - $1.48 Million	-5,844 Reduced 4.3%	129,964 $28.9 Million
Q1 2023 May 15, 2023	SELL	$225.79 - $275.2 $897,289 - $1.09 Million	-3,974 Reduced 2.84%	135,808 $32.8 Million
Q4 2022 Feb 14, 2023	SELL	$229.03 - $291.01 $1.03 Million - $1.3 Million	-4,478 Reduced 3.1%	139,782 $36.7 Million
Q3 2022 Nov 14, 2022	SELL	$224.46 - $253.15 $1.56 Million - $1.76 Million	-6,962 Reduced 4.6%	144,260 $31.9 Million
Q2 2022 Aug 15, 2022	SELL	$230.71 - $256.74 $2.44 Million - $2.72 Million	-10,586 Reduced 6.54%	151,222 $36.1 Million
Q1 2022 May 16, 2022	BUY	$219.27 - $242.57 $2.07 Million - $2.29 Million	9,437 Added 6.19%	161,808 $39.1 Million
Q4 2021 Feb 14, 2022	BUY	$198.88 - $227.6 $340,283 - $389,423	1,711 Added 1.14%	152,371 $34.3 Million
Q3 2021 Nov 15, 2021	SELL	$212.27 - $248.7 $46 Million - $53.9 Million	-216,607 Reduced 58.98%	150,660 $32 Million
Q2 2021 Aug 16, 2021	SELL	$233.58 - $259.14 $1.7 Million - $1.88 Million	-7,269 Reduced 1.94%	367,267 $89.5 Million
Q1 2021 May 14, 2021	BUY	$221.91 - $258.6 $199,275 - $232,222	898 Added 0.24%	374,536 $93.2 Million
Q4 2020 Feb 16, 2021	BUY	$216.38 - $257.67 $33.6 Million - $40 Million	155,186 Added 71.04%	373,638 $85.9 Million
Q3 2020 Nov 12, 2020	SELL	$234.65 - $260.95 $932,968 - $1.04 Million	-3,976 Reduced 1.79%	218,452 $55.5 Million
Q2 2020 Aug 14, 2020	SELL	$197.81 - $242.74 $379,003 - $465,089	-1,916 Reduced 0.85%	222,428 $52.5 Million
Q1 2020 May 06, 2020	SELL	$182.24 - $241.7 $110,801 - $146,953	-608 Reduced 0.27%	224,344 $45.5 Million
Q4 2019 Feb 13, 2020	SELL	$189.21 - $243.2 $1.27 Million - $1.63 Million	-6,698 Reduced 2.89%	224,952 $54.2 Million
Q3 2019 Nov 13, 2019	SELL	$174.11 - $208.62 $29,772 - $35,674	-171 Reduced 0.07%	231,650 $44.8 Million
Q2 2019 Aug 16, 2019	SELL	$166.7 - $195.41 $985,863 - $1.16 Million	-5,914 Reduced 2.49%	231,821 $42.7 Million
Q1 2019 Apr 12, 2019	SELL	$180.87 - $203.88 $236,035 - $266,063	-1,305 Reduced 0.55%	237,735 $45.2 Million
Q4 2018 Jan 30, 2019	SELL	$178.4 - $208.25 $12.5 Million - $14.6 Million	-69,919 Reduced 22.63%	239,040 $46.5 Million
Q3 2018 Oct 15, 2018	SELL	$185.29 - $208.89 $6.6 Million - $7.44 Million	-35,628 Reduced 10.34%	308,959 $64 Million
Q2 2018 Aug 01, 2018	SELL	$166.05 - $186.51 $2.97 Million - $3.34 Million	-17,901 Reduced 4.94%	344,587 $63.6 Million
Q1 2018 Apr 20, 2018	SELL	$169.43 - $198.0 $322,255 - $376,596	-1,902 Reduced 0.52%	362,488 $61.8 Million
Q4 2017 Jan 22, 2018	SELL	$168.79 - $188.59 $8.58 Million - $9.58 Million	-50,811 Reduced 12.24%	364,390 $63.4 Million
Q3 2017 Oct 25, 2017	BUY	$167.29 - $191.0 $69.5 Million - $79.3 Million	415,201	415,201 $77.4 Million

Others Institutions Holding AMGN

# of Institutions

3,073

Shares Held

417M

Call Options Held

7.19M

Put Options Held

6.28M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $169B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of First Manhattan CO, based on Form 13F filings with the SEC.

News

Stay updated on First Manhattan CO with notifications on news.

Account

First Manhattan CO Amgen Inc Transaction History